These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mechanism of action and biological significance of prostaglandins and leukotrienes. Tomasi V; Orlandi M; Bartolini G Boll Soc Ital Biol Sper; 1984 May; 60 Suppl 4():105-9. PubMed ID: 6432006 [No Abstract] [Full Text] [Related]
23. Prostaglandins, slow-reacting substances (leukotrienes) and the lung. Seale JP Aust N Z J Med; 1981 Oct; 11(5):550-7. PubMed ID: 6798958 [No Abstract] [Full Text] [Related]
24. [Role of the eicosanoids: prostaglandins, prostacyclin, thromboxane and leukotrienes in the pathogenesis of bronchial asthma and other lung diseases]. Karaulov AV; Silvestrov VP; Pomoĭnetskiĭ VD; Zakharov VN; Masenko VP Ter Arkh; 1986; 58(3):123-30. PubMed ID: 3520918 [No Abstract] [Full Text] [Related]
25. Mechanisms underlying inflammatory edema: the importance of synergism between prostaglandins, leukotrienes, and complement-derived peptides. Williams TJ; Jose PJ; Wedmore CV; Peck MJ; Forrest MJ Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():33-7. PubMed ID: 6221544 [No Abstract] [Full Text] [Related]
26. Interactions between leukotrienes and other eicosanoids. Sirois P; Borgeat P; Rola-Pleszczynski M; Gagnon L; Hébert RL; Plante GE Prog Clin Biol Res; 1985; 199():75-84. PubMed ID: 2999826 [No Abstract] [Full Text] [Related]
27. Lipid mediators in the pathophysiology of critical illness. Bulger EM; Maier RV Crit Care Med; 2000 Apr; 28(4 Suppl):N27-36. PubMed ID: 10807314 [TBL] [Abstract][Full Text] [Related]
28. Cardiac anaphylaxis: Part II: The role of prostaglandins, thromboxanes and leukotrienes in C.A. Da Silva Machado FR; Assem ES; Ezeamuzie IC Allergol Immunopathol (Madr); 1985; 13(4):335-50. PubMed ID: 2417469 [TBL] [Abstract][Full Text] [Related]
29. Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock. Ball HA; Cook JA; Wise WC; Halushka PV Intensive Care Med; 1986; 12(3):116-26. PubMed ID: 3016060 [TBL] [Abstract][Full Text] [Related]
30. [Prostaglandins, thromboxanes and leukotrienes. Their role in cardiovascular diseases, allergic reactions and inflammation]. Maclouf J; Borgeat P; Grange MJ; Wautier JL; Caen JP Presse Med; 1984 Jan; 13(2):91-6. PubMed ID: 6320156 [TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal toxicity. Role of prostaglandins and leukotrienes. Peskar BM; Kleine A; Pyras F; Müller MK Med Toxicol; 1986; 1 Suppl 1():39-43. PubMed ID: 3547000 [TBL] [Abstract][Full Text] [Related]
32. [Biochemistry and significance of prostaglandins, prostacyclins, thromboxanes and leukotrienes and the modification of their biosynthesis by essential fatty acids]. Kolb E Z Gesamte Inn Med; 1985 Mar; 40(6):165-72. PubMed ID: 2988221 [TBL] [Abstract][Full Text] [Related]
33. Leukotrienes as mediators in tissue trauma. Denzlinger C; Rapp S; Hagmann W; Keppler D Science; 1985 Oct; 230(4723):330-2. PubMed ID: 4048937 [TBL] [Abstract][Full Text] [Related]
34. Role of leukotrienes in endotoxin action in vivo. Keppler D; Hagmann W; Rapp S Rev Infect Dis; 1987; 9 Suppl 5():S580-4. PubMed ID: 3317751 [TBL] [Abstract][Full Text] [Related]
35. [Prostaglandins, leukotrienes, anti-inflammatory substances and their importance in inflammatory reactions of the skin]. Greaves MW Hautarzt; 1982 Mar; 33(3):123-9. PubMed ID: 6282780 [TBL] [Abstract][Full Text] [Related]